Breast Cancer at JOOTRH: A Data-Driven Overview

An analysis of 188 patient profiles to understand demographics, diagnosis, and outcomes.

Patient Demographics

Age at Diagnosis

Mean Age (Years)

Median Age (Years)

Residence

Education Level

Marital Status

Occupation

Clinical Profile at Diagnosis

Tumor Stage at Presentation

A significant majority of patients are diagnosed at a late stage (III or IV), highlighting the need for earlier detection strategies.

Tumor Size (T-Stage)

Tumor Grade

Histological Subtype

The Diagnostic Journey

Method of Detection

Time to Diagnosis

Average months from first symptom to diagnosis

This delay can significantly impact treatment options and outcomes.

Healthcare Navigation

Average facilities visited before diagnosis

Access to Care

Average distance to hospital (Km)

Outcomes & Key Factors

Vital Status

Health Insurance Coverage

Treatment Insights

Receptor Status Breakdown

Receptor status is crucial for determining treatment paths, especially for hormonal and targeted therapies.

Targeted Treatment Pathways

ER-Positive & Age < 50:

Treated with Tamoxifen.

ER-Positive & Age > 50:

Treated with Letrozole or Anastrozole.

HER2-Positive & Age > 50:

Eligible for Trastuzumab (Targeted Therapy).

✨ Medical Term Explainer

Enter a medical term related to breast cancer to get a simple explanation.

Enter a term above and click 'Explain Term' to see the explanation here.

✨ Prepare for Your Appointment

Get some general questions you might ask your doctor about breast cancer.